Search Tag: Pseudomonas aeruginosa

ICU Management

Long-vs-short-duration-antibiotic-therapy-for-vap

2022 24 May

Ventilator-associated pneumonia (VAP) is a major cause of morbidity and mortality in the ICU. It accounts for nearly 25% of infections in ICU patients. While there are guidelines to treat VAP, uncertainties remain when treating VAP due to Pseudomonas aeruginosa (PA-VAP), and the optimal duration of antibiotic therapy continues to be debated. In addition,...Read more

ICU Management

New-treatment-for-antibiotic-resistant-bacteria

2017 03 Apr

A new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and care providers is described in a report in American Journal of Respiratory and Critical Care Medicine. Researchers say the unusual approach of removing antibodies from the blood stream could reduce the effects of chronic infections, the...Read more